Reported Nov 20, 2019 · Terminated
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 )…
Sato Pharmaceutical Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Sato Pharmaceutical Inc. · 20695 S Western Ave Ste 240 · Torrance, CA · 90501-1834
Is this the product you have?
4 of 4 products
| # | Product as published |
|---|---|
| 1 | 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and |
| 2 | 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 |
| 3 | Distributed by Sato Pharmaceutical INC. 20695 |
| 4 | Western Ave., Suite 240 Torrence, CA 90501 |
- Lot codes and dates
- Lot #: a) AXWA, Exp. date Feb 2021; AXAB, Exp. date May 2021; AXLK, Exp. date Nov 2021; b) AXZP, Exp. date Jul 2021
- Amount recalled
- a) 112,104 units b) 24,696 units
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
- Nationwide
Why it was recalled
Subpotent Drug
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Sato Pharmaceutical Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.